Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pavmed Inc (NQ: PAVM ) 1.230 -0.020 (-1.60%) Streaming Delayed Price Updated: 10:55 AM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Pavmed Inc < Previous 1 2 3 Next > PAVmed and Lucid Diagnostics Provide Strategic Business Update January 17, 2023 From PAVmed Inc. Via Business Wire PAVmed and Lucid Diagnostics to Provide Strategic Business Update January 11, 2023 From PAVmed Inc. Via Business Wire PAVmed Partners with Novosound on Ultrasound Imaging Technology December 22, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry December 08, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform December 15, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research December 01, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Provides Business Update and Third Quarter 2022 Financial Results November 15, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results November 14, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed to Participate in BTIG Digital Health Forum November 11, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer November 09, 2022 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum November 10, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022 November 03, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 November 02, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results August 16, 2022 From PAVmed Inc. Via Business Wire PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference August 30, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results August 15, 2022 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio August 11, 2022 From Lucid Diagnostics Inc. Via Business Wire Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies August 04, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed to Hold a Business Update Conference Call on August 16, 2022 August 03, 2022 From PAVmed Inc. Via Business Wire PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America July 19, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference July 18, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results May 12, 2022 From PAVmed Inc. Via Business Wire PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO May 13, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results May 11, 2022 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans May 09, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed to Hold a Business Update Conference Call on May 12, 2022 April 26, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022 April 25, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results March 29, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination April 04, 2022 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference March 30, 2022 From Lucid Diagnostics Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.